Stephen P. Squinto, EVP, Global Operations Officer at ALEXION PHARMACEUTICALS INC (ALXN), sold 44,125 shares at $97.46 ($4.2M) on 2013-07-01, disclosed to the SEC on 2013-07-03.
Scheduled sale ($4.2M) by EVP, Global Operations Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $94.34 | 25,175 | $2.4M | 56.7% |
| 2 | $95.16 | 11,625 | $1.1M | 26.4% |
| 3 | $96.84 | 7,285 | $705K | 16.8% |
| 4 | $97.46 | 40 | $4K | 0.1% |
| Total | $94.97 avg | 44,125 | $4.2M | 100% |
| Filing → |
| SWTX | BUY | 2019-09-19 | $5.0M | — | Filing → |
| ALXN | SELL | 2014-10-28 | $1.1M | — | Filing → |
| ALXN | SELL | 2014-10-07 | $1.7M | — | Filing → |